Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2

BACKGROUND: The receptor binding domain (RBD) of spike protein S1 domain SARS-CoV-2 plays a key role in the interaction with ACE2, which leads to subsequent S2 domain mediated membrane fusion and incorporation of viral RNA into host cells. In this study we tend to repurpose already approved drugs as...

Descripción completa

Detalles Bibliográficos
Autores principales: Prajapat, Manisha, Shekhar, Nishant, Sarma, Phulen, Avti, Pramod, Singh, Sanjay, Kaur, Hardeep, Bhattacharyya, Anusuya, Kumar, Subodh, Sharma, Saurabh, Prakash, Ajay, Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442136/
https://www.ncbi.nlm.nih.gov/pubmed/32866780
http://dx.doi.org/10.1016/j.jmgm.2020.107716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442136/
https://www.ncbi.nlm.nih.gov/pubmed/32866780
http://dx.doi.org/10.1016/j.jmgm.2020.107716

Ejemplares similares